MAX RUBENSTEIN: Open Payments
NPI 1417585159 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $122 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, AUSTEDO XR, Azstarys, Auvelity.
Industry payments across CO — which companies pay providers there.
